Editorial Board
University of South Carolina, USA
|
Biography
Dr. Mark Stephen Kindy is majored in Biochemistry and Professor/Associate Chair for Research in the Department of Regenerative Medicine and Cell Biology and Neurosciences at the Medical University of South Carolina and a Senior Research Career Scientist/Deputy Associate Chief of Staff for Research at the Ralph H. Johnson VA Medical Center in Charleston, SC. He obtained Ph.D. in Genetics from University of Havana, Cuba in 1995. In 1994 he was the Principal Investigator of the team at CIGB that developed the cattle tick commercially named GavacTM. In 2007, He moved to Australia after accepting a position at Department of Primaries Industries and Fisheries (DPIF), Queensland, as the lead scientist on a tick vaccine research program. Since 2010, his position at DPIF was transferred to the University of Queensland where currently he worked as Senior Research Fellow of ‘Queensland Alliance for Agriculture & Food Innovation’ (QAAFI). In 2013, he was granted an OECD research fellowship at the USDA- Livestock Insects Research Laboratory, Texas. He is a Member for various societies Nationally and Internationally. He was awarded for Articles Alert Review in The Scientist; Annual Certificate of Recognition, Alzheimer’s Association; Fogarty Senior Fellowship; Kentucky Colonel; Honorary Professor, Great Wall Hospital, Jinan, China; Guest Professor, Clinical Medical College of Shandong University and Shandong University Second Hospital, Jinan, China; Honorary Professor, Leling Hospital, and Honorary Citizen, Leling, China; Honorary Professor, Industrial Hospital of Shandong University, Jinan, China; Certificate of Recognition, US Department of Health and Human Resources, NIH Study Section; Nominee, 2011 South Carolina Governor’s Award for Excellence in Science, and Member, National Academy of Inventors. He is also Member of Editorial Board for many journals. He currently review for multiple peer-reviewed journals including International Journal for Parasitology, Vaccine, Ticks and Tick-borne diseases, PlosONE, Journal of Parasitology and Vector Biology, African Journal of Microbiology Research, International Journal of Molecular Sciences, Biologics: Targets and Therapy, Reports in Parasitology, Journal of Veterinary Medicine and Animal Health, International Journal of Nanomedicine, and Drug Design, Development and Therapy. He is currently consulting editor for Reports in Parasitology Journal.He published more than 168 peer-reviewed articles. He is also an author for some books and chapters. Research Interest
|  |
University of Waraswa, Poland
|
Biography
Dr. Elżbieta Katarzyna Jagusztyn-Krynicka iscurrently working as Professor in the Department of Bacterial Genetics, Institute of Microbiology, University of Waraswa, Poland. She recieved Doctoral Degree in 1974 from University of Warasaw. She is Member for various societies including Secretary of Scientific Board of the Institute of Microbiology, University of Warasaw; ASM; Polish Society of Microbiologist, and Polish Society for Genetics. She was awarded Gold medal and mention with price of Didiera Reyndersa, Belgian vice Prime Minister and Minister of Sciences on 54 th World Exhibition of Innovation, Research and New Technology, Brussels EUREKA 2005 for the innovation of ‘‘Anti Salmonella/Camphylobacter Bivalent Poultry Vaccination-2005’’; Award from Polish Society for the best academic text book of ‘‘Molecular Genetics” in the field of Genetics in 2004-2006, and award from Ministry of Sciences and Higher Education for the academic text book of ‘‘Molecular Biology of Bacteria” in 2008. She is also serving as an Editorial Board Member for Journal of Infection in Developing courntries JIDC; The Open Vaccine Journal; Kosmos; Polish Journal of Microbiology; Vaccine Development and Therapies, and for International Journal of Veterinary Medicine: Research & Reports. External Reviewer for scientific journal including Acta Microbiologica Polonica; Advances in Microbiology; Acta Biochimica Polonica; J.Appl.Genetics; Vaccine; CMLS-Cellular and Molecular Life Sciences; Archieves in Microbiology; FEBS Letters; Plazmid; IJMM; J.Bacteriol, Helicrobacter, Microbiology; Future Medicine, and others. Research Interest
|  |
Pennsylvania State University, USA
|
Biography
Dr. Jianxun Song is currently Tenured Associate Professor, Department of Microbiology and Immunology, The Pennsylvania State University College of Medicine, Hershey, PA, USA. He received Ph.D. in 2001 in Immunology from The Third Military Medical University, China. Dr. Jianxun Song served as PI for 11 Research Projects and also serving as PI for 3 ongoing Research Projects. He is the Member of American Association for Cancer Research (AACR), and American Association of Immunologist (AAI). He was awarded for AAI Junior Faculty Travel Awards; Dean’s Awards for Excellence in Teaching; Graduate Council, the Graduate School, Penn State University; Postdoctoral Mentorship Award; Woodward Education Scholar Award and Penn State University Faculty Senate. He is an Editorial Board Member for Annals of Cancer Research; American Journal of Cancer Research; Journal of Cancer Therapeutics and Research; Journal of Tuberculosis Research; Journal of Microscopic Creatures; Journal of Antibiotics Research; Clinical Journal of Microbiology and Pathology; Oncology Discovery; Breast Cancer Reports; Austin Journal of Microbiology; Immunological Journal (Immunol.J.); International Journal of Vaccines and Research; International Biological and Biomedical Journal and SOJ Immunology. He also Peer Reviewer & Grant Reviewer for Melanoma Research Foundation; The Board Foundation; The Arthritis Research UK; The National Center of Science and Technology Evaluation; The Netherlands Organization for Scientific Research - NWO Vidi programme; The Dutch Cancer Society; Dutch Arthritis Association; The Landsteiner Foundation for Blood Transfusion Research; University of Pune and for many others also as Manuscript Reviewer. Research Interest
|  |
Schneider Children's Medical Center, Israel
|
Biography
Dr. Shai Ashkenaziis Currently Professor of Pediatrics at Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Director for Pediatrics (A) at Schneider Children's Medical Center of Israel, Petah Til Aviv, Israel. He received Doctoral Degree in 1977 and obtained Board Certificate in Infectious Diseases (1991) as well as in Pediatrics (1987). He served as a PI and CoPI for many research projects. He is Member of various societies including Israel Medical Association; Israel Pediatric Association; Israel Society for Clinical Pediatrics; American Society for Microbiology; American Society for Clinical Research; Pediatric Infectious Diseases Society, USA; Israel Society for Infectious Diseases; Israel Society for Epidemiology; Israel Society for Microbiology, and European Society for Paediatric Infectious Diseases. He was awarded for Young Investigator Award nominee, Pediatric Infectious Diseases Society, USA; Dean's Award of Excellence in Teaching, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; The Jack Kemp Award for the contribution to the excellence of Schneider Children’s Medical Center of Israel; Director General Award for Excellence, Clalit Health Services, and Moran award for excellent scientific publication, Department of Pediatrics, Sackler Faculty of Medicine, Tel Aviv University. He is an Editorial Board Member for Israel Journal of Pediatrics; Israel Medical Association Journal; The Open Pediatric Medical Journal; World J Clinical Infectious Diseases; National Scientific Committee for Orphanet (rare diseases) Israel; Therapeutic Advances in Vaccines; Pediatirc Infectious Diseases Journal, Community-Acquired Infections and also Reviewer for many Journals. He is also an author for “Text Book of Pediatriacs” by S. Ashkenazi, M. Shohat for two Editions. He published 192 Original Research Articles, 22 Case Reports, 34 Review articles, and had 25 Chapters in various Books. Research Interest
|  |
Rochester General Hospital Research Institute, USA
|
Biography
Dr. Qingfu Xu is currently Senior Scientist at Center for Infectious Disease & Immunology, Rochester General Hospital Research Institute, Rochester, Newyork, USA. He received Ph.D. in Agriculture in 2002 from Veterinary College, Nanjing Agricultural University, Nanjing, P. R. China. He also conducting research as a PI on Vaccine Immunology focusing on immunological and molecular mechanism of protection by multivalent Pneumococcal Protein Vaccine (mPPV) against pneumonia and Acute Otitis Media (AOM) in animal mode, Viral-Bacterial interaction and copathogenesis of respiratory tract infections in children and mouse model, and Correlation of mucosal innate immune responses to target component proteins of mPPV with AOM in children. He was awarded for The first author paper titled "Nasopharyngeal Bacterial Interaction in Children" published in the Emerging Infectious Disease Journal has been selected as one of US Continued Medical Education (CME) articles, allowing all US clinicians to earn CME credits by completing learning objectives; Excellent Student Scholarship of Henan Dingli Chongyang Animal Feedstuff Inc., China; Provincial Excellent Teaching Awards - Sichuan Province Government, China, and Excellent Teaching Awards, 1st place, Southwest University Rongchang Campus. He also serving as Ad Hoc Reviewer of following journals - Applied and Environmental Microbiology; Clinical and Vaccine Immunology; Clinical and Experimental Immunology; Journal of Bacteriology; Infection and Immunity; Journal of Clinical Microbiology; Journal of Microbiology and Antimicrobials; Clinical Infectious Diseases, and International Journal of Pediatric Otorhinolaryngology. He published 34 Peer-reviewed journal papers in English and 35 Peer-reviewed journal papers in Cinese. Research Interest
|  |
Emory University, USA
|
Biography
Dr. Mohan Maddur Sathyanarayana is currently working as Research Fellow at Emory Vaccine Center at Yerkes, Emory University School of Medicine, Atlanta, USA. He received Doctor of Philosophy in Immunology from Pierre and Marie Curie University, Paris, France. Mohan M. Sathyanarayana is Member of America Association Immunologists; Society for Toxicological Pathology in India, and Indian Association of Veterinary Pathologists. He was awarded Dr. C.M. Singh Best Research Article in Indian Journal of Veterinary Pathology; Trainee Abstract Award by American Association of Immunologists, and Young Scientist award. He has 36 publications in Peer-Reviewed journals with Editorial Board and Reviewer for Journal of Leukocyte Biology; PLOS one; The Journal of Rheumatology; Expert Reviews of Clinical Immunology; Autoimmunity; Central European Journal of Biology; Journal of Vaccines; Cytokine; Advances in Epidemiology; Human Immunology; Arthritis Research and Therapy, and Veterinaty World. Research Interest
|  |
University of Florida, USA
|
Biography
Dr. Xinghong Yang is a Researcher in Microbial Pathology at the Department of Infectious Diseases & Pathology, College of Veterinary Medicine, University of Florida, Gainesville, USA. He obtained his Ph.D. from China Agricultural University, Beijing, China. He has rich experience in Molecular Microbiology, Pathology, and Immunology. His expertise lays in Infectious Bacterial Diseases, including Brucella, Salmonella, Yersinia, and Enterotoxigenic E. coli, focusing on vaccine development for these pathogens. Particularly, the Brucella vaccine he constructed is entering the large animal test phase. In cooperation with scientists, his research also involves in the Immuno-Immobilization of Bacterial pathogens. He served as the Reviewer for a number of Academic Journals, Grant Reviewer for a few important institutes, and Editor for a couple of Scientific Journals. Research Interest
|  |
Kansas State University, USA
|
Biography
Dr. Rahul Mahavir Nandre is currently Research Scientist in the Department of Diagnostic Medicine and Path Biology, College of Veterinary Medicine, Kansas State University, Mahattan, Kansas, USA. He obtained Ph.D. in Veterinary Medicine in 2013 from the College of Veterinary Medicine, Chonbuk National University, South Korea. He was awarded for Brain Korea-21 Scholarship during doctoral study and Indian Council of Agricultural Research Merit-Cum Scholarship during Bachelor study. He is an Editorial Board Member for Journal of Bacteriology and Mycology, and International Journal of Pharmaceutical Sciences Review and Research. He is also serving as Reviewer for Vaccine; Annals of Clinical Microbiology and Antimicrobials; Veterinary Immunology and Immunopathology, and Comparative Immunology, Microbiology and Infectious Diseases Journals. He is an author for Book (Salmonella Pathogenesis and Progression in the Development of Human and Veterinary Non-Typhoidal Salmonella Vaccines against Human Salmonellosis) and for many peer reviewed publications. Research Interest
|  |
University of Texas, USA
|
Biography
Dr. Amit Kumar is currently Formulation Scientist at QS Pharma, Boothwyn, Pennsylvania, USA. He obtained Ph.D. in Pharmceutics in 2013 from the College of Pharmacy, University of Texas, Austin, Texas. He is a Member of Scientific Societies including American association of pharmaceutical scientists; Delaware Bioscience Association; Indian pharmaceutical congress (2003), and Indian society for technical education (2005). He was awarded with PGSA travel scholarship award, University of Texas at Austin, Butler University Master’s degree academic scholarship, and Lilly Endowment scholarship award. He is Reviewer for Drug Development and Industrial Pharmacy; Journal of Controlled Release; Molecular Pharmaceutics; Colloids and Surfaces B: Biointerfaces; Journal of Pharmaceutical Sciences; Nanomedicine: Nanotechnology, Biology, and Medicine; International Journal of Nanomedicine; Research and Reports in Transdermal Drug Delivery Clinical, Cosmetic And Investigational Dermatology; Vaccine: Development and Therapy; Elsevier (Book proposals); American Association of pharmaceutical scientist (Abstract screener). He is an author for some peer reviewed publications and a Book Chapter. Research Interest
|  |
University College of London, United Kingdom
|
Biography
Dr. Mikel Anthony Whelan is currently Biochemist and Immunologist and Director of Research & Development at iQur Biotechnology Company, London Bioscience Innovation Centre (Royal Veterinary College), London, United Kingdom. He was Head of Research and Development at the company till 2013; he also worked as Head of Scientific Operations (iQur Ltd), Head of Research (Onyvax Ltd.), and Head of Immunology in 2003 (Onyvax Ltd). He obtained Ph.D. in Immunology in 1993 from University of London. He is a Member of British Society of Immunology, and Fellow of Society of Biology. He was a Section Editor for Current Opinion in Molecular Therapeutics (2007-2010). He published 39 peer reviewed articles and has 4 patents in the scientific research. iQur’s lead product is a universal Influenza Vaccine which is partly funded by the EU FP7 FLUTCORE project. Mike wrote and is the Co-ordinator of the grant. Mike is also an Honorary Lecturer at both University College London and Royal Veterinary College. Research Interest
|  |
University of Messina, Italy
|
Biography
Dr. Antonio Simone Laganà is currently Professor in the Department of Pediatric, Gynecological, Microbiological and Biomedical Sciences, University of Messina, Italy. He is Member of Italian Association of Endometriosis Expert Panel; In-Training Member of the Society for Reproductive Investigation; European Society of Human Reproduction and Embryology; International Society of Gynecological Endocrinology; Italian Society of Gynecology of Childhood and Adolescence; Italian Society of Gynaecological Endoscopy, and of Giorgio Pardi Foundation’s Professional Research Team. He got a Master of “Gynaecological Minimally Invasive and Robotic Surgery”. He received “Medela” award 2012 for the best proposed research ideas and “Buonasanita award 2013” from “Centro Studi La Fenice”. He is Member of the Editorial Board for Euro Mediterranean Biomedical Journal; Journal of Pain & Relief; Biotechnology, Molecular Biology and Nanomedicine; Gynecology & Obstetrics; Journal of Applied Medical Sciences; Scholars Journal of Applied Medical Sciences; Scholars Academic Journal of Biosciences; Endocrinology & Metabolic Syndrome; International Journal of Obstetrics and Gynecology Research; Trends Journal of Sciences Research; American Journal of Microbiology and Biotechnology; International Journal of Clinical Medicine Research; Research Open Journal of Obstetrics and Gynecology, and International Journal of Medical and Pharmaceutical Case Reports. Research Interest
|  |
Gunma University, Japan
|
Biography
Dr. Masashi Emoto is currently Professor of Gunma University Graduate School of Health Sciences in Japan. He got the professorship in 1993 and his main Research theme is on NKT cells. Before coming back to Japan, he has worked at Max Planck Institute for Infection Biology as a higher ranking senior scientist with Prof. Dr. Stefan H. E. Kaufman, who is now a President of International Union of Immunological Societies, and published many articles in prestigious journals with high impact factor. He received his Doctoral Degree in 1991 from Department of Bacteriology, Nara Medical University in Kashihara, Nara, Japan. He has concentrated on identification of new natural ligand(s) for invariant NKT cells and he has succeeded to determine their chemical structures. Thus, he is a leading scientist in the field of NKT cells. He has Membership in various societies including Japanese Society for Bacteriology; Japanese Society for Immunology (council); German Science Foundation; American Association of Immunologist, and Japanese Society for Host Defense Research (Council). Associate Editor for Microbiology and Immunology - published by Japanese Society for Bacteriology; Japanese Society for Virology & Japanese Society for Host Defense Research. Editorial Advisory Board for Current Immunology Reviews; The Open Immunology Journal and Open Microbiology Journal - published by Bentham Science Publishers Inc. Research Interest
|  |
University of Queensland, Australia
|
Biography
Dr. Manuel Rodriguez Valle is working as Senior Research fellow at The University of Queensland/Queensland Alliance for Agriculture & Food Innovation (QAAFI), Carmody Rd, St Lucia, Brisbane (Australia). He obtained Ph.D. in Genetics in 1995 at the same University. He reveived National Patent Office Award: The Best Patent in 2001; Gavac vaccine against B. microplus, and Science and Technology Forum Award to Integrated Control against B. microplus based on Gavac vaccine. He is also an Editor cum Reviewer for International Journal for Parasitology; Vaccine; Ticks and Tick-borne diseases; PlosONE; Journal of Parasitology and Vector Biology; African Journal of Microbiology Research; International Journal of Molecular Sciences; Biologics: Targets and Therapy; Reports in Parasitology; Journal of Veterinary Medicine and Animal Health; International Journal of Nanomedicine; Open Access Insect Physiology, and International Journal of High Throughput Screening. His research areas include Development of the Vaccine against the Cattle Tick, Expression and Purification of Recombinant Proteins such as Bovine Interferon Omega, Human Tissular Plasminogen Activator (TPA) and other Pharmacological Proteins at the same institute. Research Interest
|  |
Central Queensland University, Australia
|
Biography
Dr. Andrew Taylor-Robinson is Professor of Immunology & Haematology and Deputy Dean (Research) in the School of Medical & Applied Sciences, Central Queensland University, Rockhampton, Australia. He received PhD in 1991 in Parasite Immunology from the Department of Zoology, University of Glasgow, UK. He has been awarded FHEA, FRCPath, FSB, FIBMS, FACTM and FASM. He is an Editorial Board Member for ISRN Immunology, Open Parasitology Journal, Open Vaccine Journal, Journal of Infectious Diseases & Immunity, Infectious Disease Reports, American Journal of Infectious Diseases & Microbiology, Immunity & Diseases, Journal of Antimicrobial Drug Design &Therapy, Annals of Medical Entomology, Annals of Vaccines & Immunization, Journal of Applied Medical Sciences, Scientifica (parasitology subject area). He has published over 80 peer-reviewed journal papers, 17 book chapters and 20 invited commentaries. Research Interest
|  |
Federal University of Rio de Janeiro, Brazil
|
Biography
Dr. Alexandre Morrot is Currently Associate Professor of Immunology, Institute of Micro-Biology at the Federal University of Rio de Janeiro, Brazil. He obtained his Ph.D. in Immunology in the year of 2000 from Federal University of Rio de Janeiro, Brazil. He serving as Principal Investigator (PI) at the Laboratory of Cell Biology at Federal University of Rio de Janeiro, where he investigates the Immunological mechanisms associated with changes in central and peripheral lymphoid system in infectious diseases, with major focus in Malaria, Leishmaniasis and Chagas Diseases. He is also serving as an Editorial Board Member for Immunity and Diseases; Journal of Vaccines & Vaccination; Pharmacologia; International Journal of Vaccines and Research. He published over 44 peer-reviewed research articles. There is a book chapter authored by Dr. Alexandre Morrot on “Relationship between Virus Infections and the Number of Extrathymic Activated CD4+, CD8+ T-Cells”. Research Interest
|  |
Szent Istvan University, Hungary
|
Biography
Dr. Dénes Béla is currently an Adjunct Professor at Department of Microbiology and Infectious Diseases, Szent István University, Ph.D. School of Veterinary Science, Budapest, Hungary (Europe). In 1996, he was appointed Director of the Institute of Animal Health in Békéscsaba, Hungary. From 2003 to 2006 he was Visiting Scientist at the Loma Linda University, School of Medicine, Center for Molecular Biology & Gene Therapy, California. In 2005, he was appointed Deputy Director for the Central Veterinary Institute (now the Veterinary Directorate of the National Food Chain Safety Office) and Head of Department of Immunology and Monoclonal Antibody Core Facility. He received Ph.D. in 1994 from the Hungarian Academy of Sciences in the dicipline of Veterinary Sciences. In 2010, he become a Member and Doctoral Supervisor of Szent István University, PhD School of Veterinary Science, Budapest, Hungary. He is Member of several organisations including The Hungarian Society for Microbiology; The Hungarian Society for Immunology, and The Hungarian Society for Zoonotic Diseases. He is Reviewer for numerous journals including Vector-Borne and Zoonotic Diseases and Acta Veterinaria Hungarica. He published 40 peer-reviewed papers. Research Interest
|  |
Serum Institute of India Ltd, India
|
Biography
Dr. Hitt Jyoti Sharma is working as Additional Director in the Medical Affairs Department at Serum Institute of India Ltd, Pune (India), a leading Institute and the largest manufacturer of vaccines in India, exporting vaccines through WHO, UNICEF, PAHO to more than 140 countries, worldwide. He is an expert in Vaccine Clinical Trials and is responsible for organizing and monitoring clinical trials. He is Member of Indian Association of Vaccinology and Immunology; Association of Prevention and Control of Rabies in India; Society of Pharmaco-Vigilance India, and Indian Academy of Pediatrics. He is also serving as an Editorial Board Member for Journal of Infectious Diseases and Therapeutics; Journal of Vaccines and Immunology; Journal of HIV for Clinical and Scientific Research; Vaccine Segment, Segment Journals; Journal of Applied Pharmaceutical Sciences and Clinical Research; Journal of Currents in Pharmacology - Genomics and Toxicology, and Pharmaceutical Regulatory Affairs Journal. Apart from this he is an External Reviewer for Vaccines; Human Vaccines, and Journal of Virology and African Journal of Biotechnology. Dr. Sharma has pioneered methods for the design, implementation, and evaluation of effectiveness in clinical trials of newer vaccines. He carried out Vaccine Research Projects including projects on Anti-Rabies Vaccines, MMR, DPT, BCG, Hepatitis-B, Haemophilus influenzae type b & various Pediatric Combination Vaccines including Liquid Pentavalent and Quadravalent Vaccine. His research also includes Herbal Drug in BPH patients (Pygeum africanum) and a Percutaneous BCG Vaccine (Onco-BCG) in Transitional Cell Carcinoma of Urinary Bladder. Research Interest
|  |
Research Institute for Biological Safety Problems, Republic of Kazakhstan
|
Biography
Dr. Kaissar Tabynov is currently Head of the Laboratory of Infectious Disease Prevention of the Research Institute for Biological Safety Problems (Republic of Kazakhstan), and qualified expert in the field of Biotechnology and Vaccinology. He received Ph.D. in 2011 from Kazakh National Agrarian University, Almaty, Republic of Kazakhstan. He is Member of International Society for Influenza and other Respiratory Virus Diseases; Scientific Council of the Research Institute for Biological Safety Problems (RIBSP); Commission on Scientific and Technical Examination of Scientific Articles, and Abstracts and Applications for Patent and Licensing Activities. Dr. Tabynov was the winner of the Republican Youth Awarded "Zhastar-2011"; Diploma of the Ministry of Education and Science of the Republic of Kazakhstan for his contribution to the development of education and science in 2012; he was also awarded in the field of "Biology and Medicine" by the Foundation of the First President of the Republic Kazakhstan- Leader of the Nation; In 2013, State Scientific Scholarship for talented young scientists, and in 2014 he won a state Youth Award "Daryn" of the Government of the Republic of Kazakhstan in the category "Science". He is also serving as Editorial Board for the Journal of Vaccines and Immunology. Guest Reviewer for International Journals Vaccine, International Journal of Nanomedicine and Frontiers in Immunology. He is an author for 50 scientific works including 22 inventions. Research Interest
|  |
Novartis Vaccines and Diagnostics, Italy
|
Biography
Dr. Tresor Bodjick Muena Mujobu currently a Medical Doctor and completed his M.D in 2009 from the University of Kinshasa, Democratic Republic of the Congo. He holds Master’s degree in Vaccinology and Pharmaceutical Clinical Development in Siena, Italy. During this program, Journal Clubs were held and led by Dr Simonetta Viviani, where he learned to criticize peer-reviewed articles in the field of Vaccines and Infectious Diseases. From May to October 2014, he was an intern at Novartis vaccines in Siena (now GSK) where he involved in clinical trials projects. His thesis is on “The Inequality of vaccination coverage between urban and rural areas in sub-Saharan Africa: the caregivers’ perspective”. Research Interest
|  |
University of Dammam, Saudi Arabia
|
Biography
Dr. Yehia Saleh Ahmed Mohamed is currently Assistant Professor in the Department of Microbiology, University of Dammam, Saudi Arabia. He obtained Ph.D. in Immunology in 2011 from Department of Infection, Immunity and Inflammation, College of Medicine and Biological Sciences, Leicester University, UK. He is also Principle Investigator for the Research Projects. He is a Member for the International and National Scientific Societies including British Society of Immunology; European Association for Cancer Research; Saudi Society for Infectious Diseases and Microbiology; Egyptian Syndicate of Pharmacists, and Egyptian Society of Immunology. He was awarded with fully funded Scholarship and Leicester University award for best posters, postgraduate competition. He is an Editorial Board Member for Bio Accent Immunology Journal, and Assistant Editor for MOJ Immunology. Reviewer for Africa Development and Resources Research Institute Journal; Omics Publication Group, and International Journal of Vaccines and Immunization. Research Interest
|  |
US Army Medical Research Institute of Infectious Diseases, USA
|
Biography
Pamela J. Glass, Ph.D., has a long history in biodefense research with over 15 years of experience in viral vaccine, therapeutic and animal model development. Her lab is currently focused on the development of medical countermeasures for biodefense needs. Specifically her research efforts include the development and characterization of vaccines against filoviruses and alphaviruses, broad spectrum therapeutics against diverse set of viral agents, and animal model development for eventual licensure of these medical countermeasures. These projects involve studies to examine the effectiveness and targets of potential therapeutics against viruses in vitro and in vivo, as well as safety and efficacy of vaccines in animal models of infection. Research Interest
| .jpg) |
University of Texas , USA
|
Biography
Mr. Sachin Thakkar is currently a final year graduate student at the University of Texas at Austin, Texas, USA. He is currently working on a novel rapid freezing technology to prepare dry powder vaccines using aluminum salt as an adjuvant, to overcome its long lasting problem of aggregating upon freezing. He is also working on the mucosal delivery these powder vaccines to enable needle free immunization. Additionally, he is also working on understanding the mechanisms of the better adjuvant activity of the aluminum nanoparticles, and microneedle based transdermal nanoparticulate vaccine delivery systems. His research article was chosen as a cover story by the Journal of Controlled Release. He is also recipient of theAmerican Association of Pharmaceutical Scientists (AAPS) Graduate Student Research Award in Biotechnology, and American Association of Indian Pharmaceutical Scientists (AAiPS) Graduate Student Research Award 2016. He was also awarded Dean’s fellowship at the University of Texas at Austin. He serves as a student representative for the Manufacturing Science and Engineering section (MSE), and secretary for the Excipient Focus Group (EFG) at the AAPS organization. He is Reviewer for more than 10 different journals and is serving on editorial board for around 8 journals. He has authored some peer reviewed publications, invited book chapters and review papers as well. Research Interest
|  |
